San Diego, CA, United States of America

Mitokor, Inc.


USPTO Granted Patents = 33

% Expired Patents = 21.2

Forward Citations = 609

Loading Chart...
Loading Chart...

30 inventors (with patents filed for the assignee):

goldMedal Robert E Davis (19 out of 145 patents)

silverMedal Soumitra S Ghosh (14 out of 59 patents)

bronzeMedal Corinna Herrnstadt (12 out of 25 patents)

4.  Eoin D Fahy (5 out of 8 patents)

5.  William Christensen Clevenger (4 out of 10 patents)

6.  Christen M Anderson (3 out of 13 patents)

7.  Anne N Murphy (3 out of 6 patents)

8.  Scott W Miller (3 out of 6 patents)

9.  Walter H Moos (3 out of 40 patents)

10.  Mark Johnson (3 out of 3 patents)

11.  Firas Abdul-Majid Rasoul (3 out of 3 patents)

12.  N Joe Maeji (3 out of 3 patents)

13.  Nathan Pollock (3 out of 3 patents)

14.  James A Dykens (2 out of 3 patents)

15.  Sandra Eileen Wiley (2 out of 7 patents)


Core Competencies:
Mitochondrial Function
Diabetes Diagnostics
Anti-Obesity Agents
Calcium Screening Assays
Mitochondrial Components
Cellular Responses
Mitochondrial DNA
Cobalt-Porphyrin Complexes
Diagnostic Assays
Mutational Burden
Mitochondria-Associated Diseases
Energy Transfer

33 patents:

Mitokor, Inc. is a biotechnology company based in San Diego, California, focused on developing innovative therapies aimed at enhancing mitochondrial function. The organization specializes in research related to cellular energy production and its implications for various health conditions. By leveraging advanced scientific insights, Mitokor aims to address unmet medical needs through its proprietary technologies, contributing to the evolving landscape of regenerative medicine and therapeutic interventions.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

33 Patents

#192 in San Diego, CA

#2,460 in California

#10,297 in US

#20,130 in the World

San Diego, CA (US)
San Diego, CA, United States of America
Forward Citations = 609

30 inventors:

Please report any incorrect information to [email protected]
Loading…